Bernard H Bochner Selected Research

Urachal adenocarcinoma

1/2022

Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bernard H Bochner Research Topics

Disease

77	Urinary Bladder Neoplasms (Bladder Cancer) 03/2022 - 03/2002
65	Neoplasms (Cancer) 10/2022 - 01/2003
37	Carcinoma (Carcinomatosis) 05/2022 - 12/2005
7	Non-Muscle Invasive Bladder Neoplasms 01/2021 - 11/2006
6	Disease Progression 01/2021 - 11/2006
6	Carcinoma in Situ 01/2019 - 09/2004
5	Margins of Excision 10/2020 - 01/2003
5	Lymphatic Metastasis 08/2020 - 05/2012
5	Transitional Cell Carcinoma 06/2008 - 08/2005
3	Pathologic Constriction (Stenosis) 12/2022 - 12/2019
3	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 05/2010
3	Hernia (Hernias) 02/2016 - 06/2014
3	Pain (Aches) 02/2016 - 05/2015
2	Neoplasm Metastasis (Metastasis) 08/2020 - 01/2019
2	Ileus 01/2020 - 12/2018
2	Carcinogenesis 12/2017 - 10/2015
2	Infections 05/2015 - 04/2012
2	Urologic Neoplasms (Urological Cancer) 09/2006 - 05/2004
1	Small Cell Carcinoma 10/2022
1	Urachal adenocarcinoma 01/2022
1	Pathologic Complete Response 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Urethral Neoplasms (Urethral Cancer) 01/2020
1	Nausea 11/2019
1	Fatigue 11/2019
1	Lymphadenopathy 01/2019
1	Urologic Diseases (Urinary Tract Disease) 01/2019
1	Bone Diseases (Bone Disease) 01/2017
1	Incisional Hernia 01/2016
1	Postoperative Pain 05/2015
1	Acidosis 10/2014
1	Paralysis (Palsy) 09/2014
1	Necrosis 03/2014

Drug/Important Bio-Agent (IBA)

11	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 08/2006
10	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 11/2004
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2014
6	Gemcitabine FDA Link 01/2022 - 11/2008
5	PlatinumIBA 05/2021 - 04/2014
4	Pharmaceutical PreparationsIBA 10/2020 - 09/2010
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2014
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
3	Biological ProductsIBA 01/2018 - 05/2010
2	B7-H1 AntigenIBA 01/2022 - 01/2021
2	atezolizumabIBA 01/2022 - 01/2017
2	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 05/2021 - 12/2020
2	ChromatinIBA 12/2017 - 02/2015
2	EnzymesIBA 06/2014 - 03/2004
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 09/2006 - 08/2005
1	Tobacco Smoke Pollution (Passive Smoking)IBA 05/2021
1	CotinineIBA 05/2021
1	Nicotine FDA Link 05/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2020
1	AntibodiesIBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 04/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2017
1	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2017
1	Lysine (L-Lysine)FDA Link 06/2017
1	Everolimus FDA Link 04/2017
1	AndrogensIBA 01/2017
1	Opioid Analgesics (Opioids)IBA 05/2015
1	Analgesics (Analgesic Drugs)IBA 05/2015
1	Phosphotransferases (Kinase)IBA 02/2015
1	Cyclin-Dependent Kinase Inhibitor p16IBA 02/2015
1	5-aminolevulinic acid hexyl ester FDA Link 10/2014
1	Photosensitizing Agents (Photosensitizers)IBA 10/2014
1	Checkpoint Kinase 1IBA 09/2014
1	CI 22IBA 06/2014
1	Peptide Hydrolases (Proteases)FDA Link 06/2014
1	AminopeptidasesIBA 06/2014
1	AlbuminsIBA 06/2014
1	LigandsIBA 03/2014
1	CytokinesIBA 03/2014
1	ChemokinesIBA 03/2014

Therapy/Procedure

76	Cystectomy 12/2022 - 03/2002
26	Therapeutics 10/2022 - 08/2005
23	Drug Therapy (Chemotherapy) 10/2022 - 08/2006
22	Neoadjuvant Therapy 10/2022 - 09/2004
22	Lymph Node Excision (Lymph Node Dissection) 10/2020 - 03/2002
12	Urinary Diversion (Ileal Conduit) 12/2022 - 01/2003
9	Nephroureterectomy 01/2019 - 01/2007
5	Adjuvant Chemotherapy 10/2022 - 01/2009
5	Immunotherapy 01/2021 - 12/2017
3	Ostomy 02/2016 - 12/2005
3	Radiotherapy 10/2015 - 05/2010
2	Blood Transfusion (Blood Transfusions) 04/2018 - 12/2005
2	Prostatectomy (Retropubic Prostatectomy) 01/2017 - 08/2012
1	Chemoradiotherapy 10/2022
1	Nicotine Replacement Therapy 05/2021
1	Perioperative Care 10/2020
1	Fluid Therapy (Oral Rehydration Therapy) 01/2020
1	Complementary Therapies (Alternative Medicine) 01/2019
1	Combined Modality Therapy 01/2017
1	Pain Management 05/2015
1	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 05/2015
1	Epidural Analgesia 05/2015
1	Transurethral Resection of Bladder 09/2014
1	Catheters 09/2014
1	Conservative Treatment 09/2014
1	Biological Therapy 03/2014